Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Loss of Measles Elimination…
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Chief of Global Health of the Biotechnology Innovation Organization (BIO), released the following statement on the loss of the United States’ measles elimination status.“The loss of…
BIO Unveils Seven-Point Plan to Secure America’s…
Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strengthWASHINGTON (November 10, 2026) - The Biotechnology Innovation…
BIO, Biocom, and California Life Sciences Sue to…
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.WASHINGTON, DC & SAN DIEGO, CA & SAN FRANCISCO, CA - The…
All Press Releases
  • Show All
Search
Results
Event Tags
September 22, 2022
Biotechnology Industry Organization (BIO) President and CEO, Dr. Michelle McMurry-Heath, released the following statement following the announcement that Congress reached an agreement on the Prescription Drug User Fee Act (PDUFA): “For 30…
September 12, 2022
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization, released the following statement in response to the Biden Administration’s “Advancing Biotechnology and Biomanufacturing” Executive Order: “BIO welcomes…
September 8, 2022
As the Biden Administration begins implementation of the Inflation Reduction Act, the Biotechnology Innovation Organization today called on the administration to take additional steps to foster the development and deployment of pioneering…
August 15, 2022
The Impact Ag & Environment Conference hosted by the Biotechnology Innovation Organization has been canceled for 2022. BIO is shifting its focus to planning a must-attend conference in Raleigh, N.C., in September 2023.BIO had planned to host the…
August 7, 2022
Senate lawmakers today passed a sweeping, $740 billion reconciliation package after an all-night session. Following the vote, Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the following…
August 5, 2022
As Senate lawmakers look to finalize a budget reconciliation package this weekend, Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement related to price controls…
July 21, 2022
BIO is hosting the Impact Ag & Environment Conference, in-person for the first time in three years, in Omaha, Neb., Sept. 19-21, 2022. Headlined by Nebraska Gov. Pete Ricketts, the event will convene leaders across the bioeconomy whose…
July 20, 2022
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week released the “Berlin Declaration” — a framework to work with G7 and G20 on a joint solution for better access to vaccines and treatments…
July 20, 2022
Washington, D.C. (July 20, 2022) – John Murphy, chief policy officer for the Biotechnology Innovation Organization, released the following statement in response to the U.S. House of Representatives’ passing the fiscal 2023 Agriculture, Rural…
July 6, 2022
Democratic lawmakers in the U.S. Senate advanced drug pricing legislation today that would drastically alter the Medicare program. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released…